Biocryst Pharmaceuticals (BCRX) EPS (Basic) (2010 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly EPS (Basic) came in at -$2.98 in Q1 2026, down 1944998.8% YoY from N/an in Q1 2025, and down 354.38% on a QoQ basis from $1.17 in Q4 2025.
Biocryst Pharmaceuticals (BCRX) EPS (Basic) (2010 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 17 years of EPS (Basic) data on file, last reported at -$2.98 in Q1 2026.
- Quarterly EPS (Basic) fell 1944998.8% year-over-year to -$2.98 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.89 (down 638.52% YoY) and the FY2025 annual result came in at $1.26, up 392.35% from the prior year.
- EPS (Basic) slipped to -$2.98 in Q1 2026, from $1.17 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $1.17 in Q4 2025 to a low of -$2.98 in Q1 2026.
- A 5-year average of -$0.28 and a median of -$0.19 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2025 — EPS (Basic) soared 1003.53% — and 2026, when it sank 1944998.8%.
- Tracing BCRX's EPS (Basic) over 5 years: stood at -$0.38 in 2022, then gained by 16.54% to -$0.32 in 2023, then jumped by 59.64% to -$0.13 in 2024, then soared by 1003.53% to $1.17 in 2025, then slumped by 354.38% to -$2.98 in 2026.
- The last three EPS (Basic) figures came in at -$2.98 (Q1 2026), $1.17 (Q4 2025), and $0.06 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 7.82 |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 1.43 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Biocryst Pharmaceuticals | 2.45 Bn | 2.10 Bn | 214.41 Mn | 0.31 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.31 |
| Mar 31, 2026 | -2.98 |
| Dec 31, 2025 | 1.17 |
| Sep 30, 2025 | 0.06 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | -0.13 |
| Sep 30, 2024 | -0.07 |
| Jun 30, 2024 | -0.06 |
| Mar 31, 2024 | -0.17 |
| Dec 31, 2023 | -0.32 |
| Sep 30, 2023 | -0.19 |
| Jun 30, 2023 | -0.40 |
| Mar 31, 2023 | -0.28 |
| Dec 31, 2022 | -0.38 |
| Sep 30, 2022 | -0.23 |
| Jun 30, 2022 | -0.32 |
| Mar 31, 2022 | -0.40 |
| Dec 31, 2021 | -0.10 |
| Sep 30, 2021 | -0.33 |